Prediction of Medium-Term Outcome by Cortisol Response to the Combined Dexamethasone-CRH Test in Patients With Remitted Depression
OBJECTIVE: Current hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the precipitation of depression. If this is the case, then normalization of initially disturbed HPA regulation should indicate a good prognosis and persis...
Saved in:
Published in: | The American journal of psychiatry Vol. 156; no. 6; pp. 949 - 951 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Washington, DC
American Psychiatric Publishing
01-06-1999
American Psychiatric Association |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | OBJECTIVE: Current hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the precipitation of depression. If this is the case, then normalization of initially disturbed HPA regulation should indicate a good prognosis and persistent HPA dysregulation should be associated with a greater likelihood of relapse or chronicity. METHOD: The combined dexamethasone corticotropin-releasing hormone test was administered twice to inpatients with major depression (N=40), once after initiation of treatment and once after remission, shortly before discharge. RESULTS: Patients with a high cortisol response on both occasions or with a substantially increased cortisol response at discharge were at much higher risk for relapse within the next 6 months than those with low cortisol responses. CONCLUSIONS: An easy-to-administer neuroendocrine test allows the prediction of medium-term outcome in patients with remitted depression. |
---|---|
AbstractList | OBJECTIVECurrent hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the precipitation of depression. If this is the case, then normalization of initially disturbed HPA regulation should indicate a good prognosis and persistent HPA dysregulation should be associated with a greater likelihood of relapse or chronicity.METHODThe combined dexamethasone/corticotropin-releasing hormone test was administered twice to inpatients with major depression (N = 40), once after initiation of treatment and once after remission, shortly before discharge.RESULTSPatients with a high cortisol response on both occasions or with a substantially increased cortisol response at discharge were at much higher risk for relapse within the next 6 months than those with low cortisol responses.CONCLUSIONSAn easy-to-administer neuroendocrine test allows the prediction of medium-term outcome in patients with remitted depression. OBJECTIVE: Current hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the precipitation of depression. If this is the case, then normalization of initially disturbed HPA regulation should indicate a good prognosis and persistent HPA dysregulation should be associated with a greater likelihood of relapse or chronicity. METHOD: The combined dexamethasone corticotropin-releasing hormone test was administered twice to inpatients with major depression (N=40), once after initiation of treatment and once after remission, shortly before discharge. RESULTS: Patients with a high cortisol response on both occasions or with a substantially increased cortisol response at discharge were at much higher risk for relapse within the next 6 months than those with low cortisol responses. CONCLUSIONS: An easy-to-administer neuroendocrine test allows the prediction of medium-term outcome in patients with remitted depression. Current hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the precipitation of depression. If this is the case, then normalization of initially disturbed HPA regulation should indicate a good prognosis and persistent HPA dysregulation should be associated with a greater likelihood of relapse or chronicity. The combined dexamethasone/corticotropin-releasing hormone test was administered twice to inpatients with major depression (N = 40), once after initiation of treatment and once after remission, shortly before discharge. Patients with a high cortisol response on both occasions or with a substantially increased cortisol response at discharge were at much higher risk for relapse within the next 6 months than those with low cortisol responses. An easy-to-administer neuroendocrine test allows the prediction of medium-term outcome in patients with remitted depression. |
Author | Holsboer, Florian Frieboes, Ralf-Michael Zobel, Astrid W. Yassouridis, Alexander |
Author_xml | – sequence: 1 givenname: Astrid W. surname: Zobel fullname: Zobel, Astrid W. – sequence: 2 givenname: Alexander surname: Yassouridis fullname: Yassouridis, Alexander – sequence: 3 givenname: Ralf-Michael surname: Frieboes fullname: Frieboes, Ralf-Michael – sequence: 4 givenname: Florian surname: Holsboer fullname: Holsboer, Florian |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1847904$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10360139$$D View this record in MEDLINE/PubMed |
BookMark | eNptkcFrFDEUxoNU7LZ69CoBxYMwazKZZCZHWW0rVFrKit5CJvPCZplJpkkG7NW_3OguWMTT4_F-3_c--M7QiQ8eEHpJyZrSVrzX-3lNuViLtWzkE7SinPGqrevuBK0IIXUlOft-is5S2peVsLZ-hk4pYYJQJlfo522EwZnsgsfB4i9lWaZqC3HCN0s2YQLcP-BNiNmlMOI7SHPwCXAOOO-gHKbeeRjwR_ihJ8g7nUq8anN3hbeQMnYe3-rswOeEv7m8KwaTy_mPYI6QUvn7HD21ekzw4jjP0deLT9vNVXV9c_l58-G60qyjubIgB9qSQYNmsqcDGNtqqvtGC2pYq7vaNqa2PQcrmeSiJaw2lslBd2SwlLJz9PbgO8dwv5R0anLJwDhqD2FJSsiOSN6KAr7-B9yHJfqSTVFOO8abhvBCVQfKxJBSBKvm6CYdHxQl6nc1qlRTBEIJVaop_Kuj69JPMDyiD10U4M0R0Mno0UbtjUt_ua5pJWkK9u6A6Xl2j5L99-kvCp2npA |
CODEN | AJPSAO |
CitedBy_id | crossref_primary_10_1016_j_jadohealth_2011_01_014 crossref_primary_10_1016_j_psyneuen_2012_12_017 crossref_primary_10_1007_s11064_007_9518_3 crossref_primary_10_1016_j_psyneuen_2015_02_013 crossref_primary_10_1016_j_jpsychires_2006_07_007 crossref_primary_10_1016_j_neubiorev_2013_11_005 crossref_primary_10_1523_JNEUROSCI_0736_05_2005 crossref_primary_10_1016_j_jpsychires_2016_11_001 crossref_primary_10_1016_j_psyneuen_2008_08_018 crossref_primary_10_1016_j_psyneuen_2010_04_016 crossref_primary_10_1146_annurev_psych_093008_100321 crossref_primary_10_1080_01612840600643040 crossref_primary_10_1111_j_1751_7893_2011_00323_x crossref_primary_10_1016_S0165_0327_00_00348_7 crossref_primary_10_1371_journal_pone_0016883 crossref_primary_10_1007_s00726_006_0333_y crossref_primary_10_1038_sj_npp_1300506 crossref_primary_10_1016_S0031_9384_01_00518_2 crossref_primary_10_1054_npep_2002_0896 crossref_primary_10_1007_s00213_006_0382_7 crossref_primary_10_1016_S0196_9781_01_00398_9 crossref_primary_10_1016_j_brainres_2014_06_008 crossref_primary_10_1016_j_jpsychires_2009_07_012 crossref_primary_10_1016_j_biopsych_2006_09_027 crossref_primary_10_1016_j_jpsychires_2011_09_020 crossref_primary_10_1177_1099800402238334 crossref_primary_10_1016_j_jpsychires_2008_05_002 crossref_primary_10_1002_cncr_22294 crossref_primary_10_1016_j_biopsych_2006_07_039 crossref_primary_10_1038_s41380_019_0585_z crossref_primary_10_1016_j_pnpbp_2017_10_015 crossref_primary_10_1210_me_2013_1187 crossref_primary_10_1038_tp_2013_98 crossref_primary_10_1590_2237_6089_2014_0031 crossref_primary_10_1016_j_neubiorev_2006_10_001 crossref_primary_10_3109_15622970109026799 crossref_primary_10_1016_j_biopsych_2006_03_075 crossref_primary_10_1016_j_pnpbp_2008_07_002 crossref_primary_10_1111_pcn_12299 crossref_primary_10_2174_1871527321666220316122605 crossref_primary_10_1016_j_biopsych_2011_07_023 crossref_primary_10_1097_00000374_200105000_00009 crossref_primary_10_3109_15622970009150573 crossref_primary_10_1038_sj_npp_1300056 crossref_primary_10_1016_j_biopsycho_2014_09_008 crossref_primary_10_1038_npp_2012_249 crossref_primary_10_1371_journal_pone_0038971 crossref_primary_10_1016_j_jpsychires_2006_01_002 crossref_primary_10_1016_S0022_3956_03_00103_1 crossref_primary_10_1038_s41398_019_0615_2 crossref_primary_10_1016_j_psychres_2012_03_044 crossref_primary_10_1053_smrv_1999_0097 crossref_primary_10_1016_j_brainres_2016_04_032 crossref_primary_10_1016_j_jadr_2021_100117 crossref_primary_10_1016_j_pnpbp_2004_01_009 crossref_primary_10_1016_S0022_3956_98_90056_5 crossref_primary_10_1016_S0165_0173_01_00082_0 crossref_primary_10_1038_sj_npp_1300280 crossref_primary_10_1038_sj_npp_1300040 crossref_primary_10_1192_bjp_bp_108_050278 crossref_primary_10_1007_s00115_015_0026_4 crossref_primary_10_1080_07853890310017044 crossref_primary_10_1016_S0301_0511_01_00089_8 crossref_primary_10_1016_S0306_4530_02_00029_X crossref_primary_10_1016_S0022_3956_00_00021_2 crossref_primary_10_1080_10253890500069650 crossref_primary_10_1097_01_nmd_0000228502_52864_ce crossref_primary_10_1590_S1516_44462004000300009 crossref_primary_10_1016_j_jad_2013_04_007 crossref_primary_10_1038_npp_2014_259 crossref_primary_10_1016_S0022_3956_01_00049_8 crossref_primary_10_1016_j_psyneuen_2014_10_022 crossref_primary_10_1016_j_yfrne_2006_05_001 crossref_primary_10_1111_j_1440_1819_2010_02135_x crossref_primary_10_3109_10673229_2011_586550 crossref_primary_10_1007_s00115_007_2370_5 crossref_primary_10_1016_j_pharmthera_2011_05_007 crossref_primary_10_1024_1661_4747_a000244 crossref_primary_10_1016_j_jad_2012_05_059 crossref_primary_10_1097_YIC_0000000000000239 crossref_primary_10_1080_15622970510030018 crossref_primary_10_1590_S1516_44462003000400010 crossref_primary_10_3109_15622970109027501 crossref_primary_10_1111_j_1530_0277_2001_tb02268_x crossref_primary_10_1038_sj_npp_1300156 crossref_primary_10_1002__SICI_1099_1077_199912_14_8_587__AID_HUP145_3_0_CO_2_2 crossref_primary_10_1016_j_yhbeh_2007_11_001 crossref_primary_10_1080_1029842021000022115 crossref_primary_10_1016_S0006_3223_02_01444_0 crossref_primary_10_1016_j_jpsychires_2010_04_015 crossref_primary_10_1192_bjp_180_1_24 crossref_primary_10_1016_j_ejphar_2004_06_035 crossref_primary_10_1016_j_psyneuen_2008_07_005 crossref_primary_10_1080_10253890701850759 crossref_primary_10_1016_j_psyneuen_2014_07_027 crossref_primary_10_1517_14728222_5_5_601 crossref_primary_10_1016_S0924_977X_03_00016_6 crossref_primary_10_1016_j_neuroscience_2006_09_023 crossref_primary_10_1111_j_1365_2826_2006_01472_x crossref_primary_10_1016_j_pnpbp_2005_03_017 crossref_primary_10_1016_S0022_3956_01_00023_1 crossref_primary_10_1016_j_biopsych_2005_09_008 crossref_primary_10_1016_j_psyneuen_2003_11_004 crossref_primary_10_1016_j_euroneuro_2004_05_004 crossref_primary_10_3389_fpsyt_2022_937582 crossref_primary_10_1016_j_psyneuen_2018_01_023 crossref_primary_10_1016_S0022_3956_01_00027_9 crossref_primary_10_1016_S0304_3940_02_00527_X crossref_primary_10_1016_j_jpsychires_2003_12_002 crossref_primary_10_1097_PSY_0b013e31816b1aaa crossref_primary_10_1590_S0101_81082005000200008 crossref_primary_10_1016_j_jpsychires_2010_04_020 crossref_primary_10_1016_j_brainres_2006_02_012 crossref_primary_10_1016_j_amepre_2006_07_002 crossref_primary_10_1016_j_jpsychires_2014_02_022 crossref_primary_10_1016_j_pnpbp_2004_05_031 crossref_primary_10_1038_oby_2002_146 crossref_primary_10_1111_jne_12070 crossref_primary_10_1080_15294145_2009_10773593 crossref_primary_10_1016_S0306_4530_01_00060_9 crossref_primary_10_1016_S0924_977X_00_80224_2 crossref_primary_10_1007_s00213_004_1984_6 crossref_primary_10_31887_DCNS_2006_8_4_mising crossref_primary_10_1097_00004714_200304000_00008 crossref_primary_10_1192_bjp_177_5_390 crossref_primary_10_2217_ijr_14_30 crossref_primary_10_1177_1359786806066063 crossref_primary_10_1016_j_jpsychires_2008_01_005 crossref_primary_10_1016_j_pnpbp_2011_10_005 crossref_primary_10_1111_j_1476_5381_2009_00585_x crossref_primary_10_1016_j_drudis_2014_02_002 crossref_primary_10_1016_S0031_9384_00_00449_2 crossref_primary_10_1016_S0022_3956_01_00013_9 crossref_primary_10_1016_S0022_3956_02_00056_0 crossref_primary_10_1016_j_yfrne_2013_12_001 crossref_primary_10_1371_journal_pone_0004324 crossref_primary_10_1026_1616_3443_34_2_121 crossref_primary_10_1016_j_jpsychires_2004_01_009 crossref_primary_10_1016_j_biopsycho_2015_05_007 crossref_primary_10_1111_j_1365_2826_2006_01516_x crossref_primary_10_1177_070674370304800703 crossref_primary_10_1016_j_psyneuen_2013_06_033 crossref_primary_10_1002_da_22125 crossref_primary_10_1016_S0014_2999_00_00677_4 crossref_primary_10_1016_S0246_1072_03_00099_3 crossref_primary_10_1586_ern_09_52 crossref_primary_10_1016_j_ejphar_2008_03_012 crossref_primary_10_1016_j_neubiorev_2005_03_003 crossref_primary_10_1016_S0165_0327_00_00352_9 crossref_primary_10_1053_beem_1999_0046 crossref_primary_10_1046_j_1601_5215_2003_00051_x |
Cites_doi | 10.1001/archpsyc.1990.01810240013002 10.1016/0022-3956(94)90017-5 10.1210/edrv-17-2-187 10.1176/ajp.143.1.18 |
ContentType | Journal Article |
Copyright | 1999 INIST-CNRS |
Copyright_xml | – notice: – notice: 1999 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION HAWNG HBMBR IBDFT K30 PAAUG PAWHS PAWZZ PAXOH PBHAV PBQSW PBYQZ PCIWU PCMID PCZJX PDGRG PDWWI PETMR PFVGT PGXDX PIHIL PISVA PJCTQ PJTMS PLCHJ PMHAD PNQDJ POUND PPLAD PQAPC PQCAN PQCMW PQEME PQHKH PQMID PQNCT PQNET PQSCT PQSET PSVJG PVMQY PZGFC 7X8 |
DOI | 10.1176/ajp.156.6.949 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Periodicals Index Online Segment 13 Periodicals Index Online Segment 14 Periodicals Index Online Segment 27 Periodicals Index Online Primary Sources Access—Foundation Edition (Plan E) - West Primary Sources Access (Plan D) - International Primary Sources Access & Build (Plan A) - MEA Primary Sources Access—Foundation Edition (Plan E) - Midwest Primary Sources Access—Foundation Edition (Plan E) - Northeast Primary Sources Access (Plan D) - Southeast Primary Sources Access (Plan D) - North Central Primary Sources Access—Foundation Edition (Plan E) - Southeast Primary Sources Access (Plan D) - South Central Primary Sources Access & Build (Plan A) - UK / I Primary Sources Access (Plan D) - Canada Primary Sources Access (Plan D) - EMEALA Primary Sources Access—Foundation Edition (Plan E) - North Central Primary Sources Access—Foundation Edition (Plan E) - South Central Primary Sources Access & Build (Plan A) - International Primary Sources Access—Foundation Edition (Plan E) - International Primary Sources Access (Plan D) - West Periodicals Index Online Segments 1-50 Primary Sources Access (Plan D) - APAC Primary Sources Access (Plan D) - Midwest Primary Sources Access (Plan D) - MEA Primary Sources Access—Foundation Edition (Plan E) - Canada Primary Sources Access—Foundation Edition (Plan E) - UK / I Primary Sources Access—Foundation Edition (Plan E) - EMEALA Primary Sources Access & Build (Plan A) - APAC Primary Sources Access & Build (Plan A) - Canada Primary Sources Access & Build (Plan A) - West Primary Sources Access & Build (Plan A) - EMEALA Primary Sources Access (Plan D) - Northeast Primary Sources Access & Build (Plan A) - Midwest Primary Sources Access & Build (Plan A) - North Central Primary Sources Access & Build (Plan A) - Northeast Primary Sources Access & Build (Plan A) - South Central Primary Sources Access & Build (Plan A) - Southeast Primary Sources Access (Plan D) - UK / I Primary Sources Access—Foundation Edition (Plan E) - APAC Primary Sources Access—Foundation Edition (Plan E) - MEA MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Periodicals Index Online Segment 14 Periodicals Index Online Segments 1-50 Periodicals Index Online Segment 27 Periodicals Index Online Periodicals Index Online Segment 13 MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-7228 |
EndPage | 951 |
ExternalDocumentID | 10_1176_ajp_156_6_949 10360139 1847904 10.1176/ajp.156.6.949 |
Genre | Journal Article |
GroupedDBID | --- --Z -DZ -~X .55 .GJ 0WA 1HT 1KJ 1QT 23M 2WC 3O- 4.4 53G 5GY 5RE 6J9 6TJ 7K8 85S 8R4 8R5 AAAHA AAIKC AAMNW AAWTL AAWTO ABIVO ABPPZ ABZEH ACBMB ACGFO ACGOD ACHQT ACNCT ADBBV ADCOW AENEX AETEA AFAZI AFFNX AFMIJ AFOSN AGHSJ AGNAY AHMBA AI. AIZTS ALMA_UNASSIGNED_HOLDINGS ASUFR BAJDF BAWUL BENPR BKOMP CS3 DIK E3Z EBS EJD EX3 F20 F5P F8P FA8 FJW G0H G8K HF~ HZ~ J5H L7B MVM N4W N9A NEJ NHB OHT OK1 OVD P-O P2P PQQKQ Q.- Q2X RAY RXW RYA S10 SJN SKT TAE TEORI TR2 TWZ UHB UKR ULE UPT UQL VH1 VVN WH7 WHG WOQ WOW X4V X6Y X7M XJT XOL XSW XZL YCJ YFH YOC YSK YWH YZZ ZCA ZGI ZRR ZXP ZY1 ~A~ ~G0 08P 1CY 2QL 354 41~ 8F7 AAJMC AAJWC AAKAS AAQQT AAYJJ ADZCM AERZD AHJKT BCR BLC GOZPB GRPMH H13 IQODW LPU LXL LXN PEA RWL UBC YQI YQJ YRY YXB YYQ ZHY ZKB ~X8 ADMHG CGR CUY CVF ECM EIF NPM AAYXX ABDPE CITATION HAWNG HBMBR IBDFT K30 PAAUG PAWHS PAWZZ PAXOH PBHAV PBQSW PBYQZ PCIWU PCMID PCZJX PDGRG PDWWI PETMR PFVGT PGXDX PIHIL PISVA PJCTQ PJTMS PLCHJ PMHAD PNQDJ POUND PPLAD PQAPC PQCAN PQCMW PQEME PQHKH PQMID PQNCT PQNET PQSCT PQSET PSVJG PVMQY PZGFC 7X8 |
ID | FETCH-LOGICAL-a381t-fe9d170daea39b1decf7a1ab4a61c37a82f4c2fb5ef939567032cf39da80df113 |
ISSN | 0002-953X |
IngestDate | Fri Oct 25 01:50:51 EDT 2024 Thu Oct 10 21:23:18 EDT 2024 Fri Nov 22 02:42:22 EST 2024 Tue Oct 15 23:21:24 EDT 2024 Thu Sep 12 02:08:35 EDT 2024 Wed Jul 24 08:11:01 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Mood disorder Human Hypothalamohypophysoadrenal axis Steroid hormone Psychotropic Treatment efficiency Peptide hormone Corticotropin releasing factor Prediction Biological marker Depression Hydrocortisone Glucocorticoid Hypothalamic hormone Dexamethasone test Chemotherapy Adrenal hormone Antidepressant agent Hormone releasing factor |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a381t-fe9d170daea39b1decf7a1ab4a61c37a82f4c2fb5ef939567032cf39da80df113 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 10360139 |
PQID | 1518354405 |
PQPubID | 1816671 |
PageCount | 3 |
ParticipantIDs | proquest_miscellaneous_69809576 proquest_journals_1518354405 crossref_primary_10_1176_ajp_156_6_949 pubmed_primary_10360139 pascalfrancis_primary_1847904 appi_journals_10_1176_ajp_156_6_949 |
PublicationCentury | 1900 |
PublicationDate | 1999-06-01 |
PublicationDateYYYYMMDD | 1999-06-01 |
PublicationDate_xml | – month: 06 year: 1999 text: 1999-06-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States – name: Washington, D.C |
PublicationTitle | The American journal of psychiatry |
PublicationTitleAlternate | Am J Psychiatry |
PublicationYear | 1999 |
Publisher | American Psychiatric Publishing American Psychiatric Association |
Publisher_xml | – name: American Psychiatric Publishing – name: American Psychiatric Association |
References | R1566BABECGHI R1566BABECBBB R1566BABDFFAD R1566BABCAEBB R1566BABDCEIC R1566BABCFBFH |
References_xml | – ident: R1566BABDFFAD doi: 10.1001/archpsyc.1990.01810240013002 – ident: R1566BABECGHI – ident: R1566BABCAEBB – ident: R1566BABDCEIC doi: 10.1016/0022-3956(94)90017-5 – ident: R1566BABCFBFH doi: 10.1210/edrv-17-2-187 – ident: R1566BABECBBB doi: 10.1176/ajp.143.1.18 |
SSID | ssj0000372 |
Score | 2.119717 |
Snippet | OBJECTIVE: Current hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the... Current hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the precipitation of... OBJECTIVECurrent hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the... |
SourceID | proquest crossref pubmed pascalfrancis appi |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 949 |
SubjectTerms | Adult Aged Biological and medical sciences Corticotropin-Releasing Hormone Depressive Disorder - blood Depressive Disorder - diagnosis Dexamethasone Female Humans Hydrocortisone - blood Male Medical sciences Middle Aged Neuropharmacology Pharmacology. Drug treatments Prognosis Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Recurrence |
Title | Prediction of Medium-Term Outcome by Cortisol Response to the Combined Dexamethasone-CRH Test in Patients With Remitted Depression |
URI | http://dx.doi.org/10.1176/ajp.156.6.949 https://www.ncbi.nlm.nih.gov/pubmed/10360139 https://www.proquest.com/docview/1518354405 https://search.proquest.com/docview/69809576 |
Volume | 156 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bi9QwFA6zK4gg4t3qrgYUX4aO01vSPMo6y4jrKussrE8lTRMYcdvSC-irv9yTNmk7LIv64EuZyfQS5vt68p3k5ByEXnFFCKUydYWvpBsKodzYFwy-piziLGBBF4y5_kJPL-J3q3A1m9nyaGPbf0Ua2gBrvXP2H9AebgoN8BkwhyOgDse_wv1zpZderA7US-ftpavt77xoG3ig1IITXM5mC_2YV32IrLQSFE4AVxlEaCZ_cF1dmoMel-7R2XoOmrQrJ2AysZptcZW83DZNd4EJqc2nenczblzJp1kqdoOsu5nrIjUBA_Nh2ucrKHu9SJCZmskD2cC_T4vewJ1N5nOL7zU0V2PAcmb297Ex7GpiolnUFQkeTXSffNxwcWpwWZ_w1IzdrE9ee3VYoF0-5G_lAu60IIvhqmn67dNPyfH5yUmyWV1s9tANHyxX56O__zAO7QH1rT-l-2iTtlLyZufmML7zstzuaJ3bJa_htVN9vZTrHZpO2GzuojvGI8FveyrdQzOZ30c3P5qYiwfo18goXCg8YRQ2jMLpT2wZhS2jcFNgYBS2jMJXGIU1o_A2x5ZRWDMKW0bhkVEP0fnxanO0dk3lDpeDAmxcJVnm0WXGJQ9Y6mVSKMo9noaceCKgPPZVCMYhjaQCcxARGHZ8oQKW8XiZKc8LHqH9HDrzBOGQcc8nOj6E-GEaRVywWC4FUeAoCxFLB73Uf3ViKFwnnVdLSQKAJABIQhIAxEGvLRJJ2adxue7Ewx2cxrNBxrFl6KADi9vkkZGn50_B93HQi-FnsNN68Y3nsmjrhLAYvBlKHPS4R3vSj4BoR-zpH699hm6Nr8wB2m-qVh6ivTprn3c8_Q0iU790 |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prediction+of+medium-term+outcome+by+cortisol+response+to+the+combined+dexamethasone-CRH+test+in+patients+with+remitted+depression&rft.jtitle=The+American+journal+of+psychiatry&rft.au=Zobel%2C+A+W&rft.au=Yassouridis%2C+A&rft.au=Frieboes%2C+R+M&rft.au=Holsboer%2C+F&rft.date=1999-06-01&rft.issn=0002-953X&rft.volume=156&rft.issue=6&rft.spage=949&rft.epage=951&rft_id=info:doi/10.1176%2Fajp.156.6.949&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-953X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-953X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-953X&client=summon |